 Enteric Capsule is a fully compliant capsule technology that simplifies drug enteric delivery implementation from early-stage development to commercial manufacturing. The pharmaceutical grades of cellulosic derivatives used in Capsugel

 Enteric capsules are approved and have extensive market precedence for use in providing enteric protection. They have been evaluated in-vitro and in-vivo across a number of compounds, which has proven full compliance with relevant European, Japanese and US Pharmacopeia monographs.

 Enteric capsules can be utilized to greatly simplify and accelerate prototype development and rapid in-vivo testing of products requiring targeted delivery to the upper GI tract:

		Eliminate coating system preparation and application steps

		Rapid screening and optimization of enteric performance

		Remove dependency of enteric functionality with process variability

		Obviate need for process development of the enteric coating step, process scale-up and validation

		Manufactured with pharmaceutical-grade cellulosic derivatives (HPMCAS, HPMC)

	Company name: Lonza Pharma & Biotech
	Website: 

www.capsugel.com/biopharmaceutical-products/vcaps-enteric-capsules

Due to the intrinsic enteric properties of Capsugel® Vcaps® Enteric, no coating step is needed. It means that this capsule is a ready-to-use solution that can help you in obtaining significant cost and time savings during pharmaceutical development or compounding.